BUSINESS4 years ago
Cannabics Pharmaceutical Inc. (OTCMKTS:CNBX) Releases RCC-33 In-Vivo Study Results Showing Its Extends Survival Rate In Mice With CRC
Cannabics Pharmaceutical Inc. (OTCMKTS:CNBX) has released concluding results for its in-vivo study evaluating the efficacy of its novel drug candidate RCC-33 in extending the survival rate...